Bone Health in Patients With Adrenal Adenomas and Hypercortisolism: A Multicenter Cross‐Sectional Study
Clinical Endocrinology · 2026
DOI: 10.1111/cen.70048 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Prerna Dogra und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Cushing Syndrome, Osteoporosis, Adrenocortical Adenoma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: This study was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institute of Aging (NIA) of the Na…, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Objective
Data on bone health in patients with mild autonomous cortisol secretion (MACS) are limited and heterogenous. We sought to assess the prevalence of osteoporosis and symptomatic fragility fractures in patients with adrenal adenomas and hypercortisolism, and explore associations with the degree of cortisol excess and frailty.
Design
This multicenter cross ‐sectional study involved prospective enrollment of adults with nonfunctioning adrenal adenomas (NFA), MACS, Cushing syndrome (CS) and referent subjects without adrenal disorders during the study period (January 2019–September 2022). All participants completed a bone health questionnaire at enrollment and had dual‐energy X ‐ray absorptiometry bone mineral density assessment within 12‐months. Final analyses were adjusted for age, sex, body mass index, smoking status, alcohol use.
Results
Participants included 117 with NFA (median age 62 years, 80% women), 191 with MACS (median age 63 years, 74% women), 62 with CS (median age 50 years, 92% women), and 101 referent subjects (median age 59 years, 47% women). Both patients with CS (OR: 3.0, 95% CI: 1.1–8.3) and MACS (OR: 2.2, 95% CI: 1.9–4.9) had a higher prevalence of osteoporosis when compared to referents. Among patients with MACS, only those with post 1‐mg dexamethasone suppression test (post‐1mg‐DST) cortisol > 83 nmol/L had a higher prevalence of osteoporosis when compared to referents (OR: 3.2, 95% CI: 1.4–7.5) and NFA (OR: 2.2, 95% CI: 1.1–4.4). For clinical fragility fractures, only patients with CS showed an increased prevalence when compared to referents (OR: 6.1, 95% CI: 1.7–26.4) and NFA (OR: 3.8, 95% CI: 1.3–11.2). Prevalence of clinical fragility fractures was similar to referents in patients with MACS (OR: 1.8, 95% CI: 0.6–6.9) and NFA (OR: 1.5, 95% CI: 0.4–6.1), and was not associated with post‐1mg‐DST cortisol or frailty in the MACS and NFA groups.
Conclusion
Patients with CS, and those with MACS and post‐1mg‐DST cortisol > 83 nmol/L, exhibited a higher burden of osteoporosis. However, only CS was associated with an elevated risk of symptomatic fragility fractures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
- Department of Internal Medicine, General Hospital Koprivnica, Koprivnica, Croatia.
- Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Internal Medicine, Division of Endocrinology, Metabolic Bone Service, Hospital for Special Surgery, New York, New York, USA.
- Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health, Detroit, Michigan, USA.
ORCID-Profile: Catherine D Zhang, Raul G Garcia, Bahaa H Salama, Darko Kastelan, Irina Bancos
Förderung
- This study was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institute of Aging (NIA) of the Na…
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Dogra, P., Šambula, L., Saini, J., Drake, M. T., Athimulam, S., Tsagarakis, S., Vassiliadi, D. A., Antonopoulou, V., Nathani, R., Zhang, C. D., Genere, N., Ambroziak, U., Hubska, J., Garcia, R. G., Bassiony, M., Salama, B. H., Atkinson, E. J., Fell, V., Kastelan, D., …, & Bancos, I. (2026). Bone Health in Patients With Adrenal Adenomas and Hypercortisolism: A Multicenter Cross‐Sectional Study. Clinical Endocrinology. https://doi.org/10.1111/cen.70048
Vancouver
Dogra P, Šambula L, Saini J, Drake MT, Athimulam S, Tsagarakis S, et al. Bone Health in Patients With Adrenal Adenomas and Hypercortisolism: A Multicenter Cross‐Sectional Study. Clinical Endocrinology. 2026. doi:10.1111/cen.70048
BibTeX
@article{Dogra2026,
author = {Dogra, Prerna and Šambula, Lana and Saini, Jasmine and Drake, Matthew T and Athimulam, Shobana and Tsagarakis, Stylianos and Vassiliadi, Dimitra A and Antonopoulou, Vasiliki and Nathani, Rohit and Zhang, Catherine D and Genere, Natalia and Ambroziak, Urszula and Hubska, Joanna and Garcia, Raul G and Bassiony, Mohamed and Salama, Bahaa H and Atkinson, Elizabeth J and Fell, Vanessa and Kastelan, Darko and Larson, Joseph J and Bancos, Irina},
title = {Bone Health in Patients With Adrenal Adenomas and Hypercortisolism: A Multicenter Cross‐Sectional Study},
journal = {Clinical Endocrinology},
year = {2026},
doi = {10.1111/cen.70048}
}
EUVIMED